Scott S. Tykodi
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 2%
- Molecular Biology top 10%
- Immunology top 2%
- Cancer Research top 5%
- Co-authors
- John A. ThompsonShailender BhatiaEdus H. WarrenDavid F. McDermottSaby GeorgeRobert J. MotzerStanley R. RiddellHans J. Hammers
- Topics
- Renal cell carcinoma treatment (61 papers)Cancer Immunotherapy and Biomarkers (44 papers)Renal and related cancers (30 papers)
- Partner nations
- United StatesUnited KingdomDenmark
In The Last Decade
Scott S. Tykodi
103 papers receiving 3.1k citations
Peers
Comparison fields: 5 of 105
- Oncology 1.9k
- Pulmonary and Respiratory Medicine 1.2k
- Molecular Biology 1.2k
- Immunology 944
- Cancer Research 543
Countries citing papers authored by Scott S. Tykodi
This map shows the geographic impact of Scott S. Tykodi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott S. Tykodi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott S. Tykodi more than expected).
Fields of papers citing papers by Scott S. Tykodi
This network shows the impact of papers produced by Scott S. Tykodi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott S. Tykodi. The network helps show where Scott S. Tykodi may publish in the future.
Co-authorship network of co-authors of Scott S. Tykodi
This figure shows the co-authorship network connecting the top 25 collaborators of Scott S. Tykodi. A scholar is included among the top collaborators of Scott S. Tykodi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott S. Tykodi. Scott S. Tykodi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 17 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 4 | |
| 6 | 9 | |
| 7 | 0 | |
| 8 | 42 | |
| 9 | 4 | |
| 10 | 3 | |
| 11 | 16 | |
| 12 | 90 | |
| 13 | 53 | |
| 14 | 8 | |
| 15 | 4 | |
| 16 | 5 | |
| 17 | 43 | |
| 18 | 160 | |
| 19 | 11 | |
| 20 | 3 |
About Scott S. Tykodi
Scott S. Tykodi is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Cancer Research, having authored 106 papers that have together received 3.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (61 papers), Cancer Immunotherapy and Biomarkers (44 papers) and Renal and related cancers (30 papers). The work is most often cited by research in Oncology (1.9k citations), Immunology (944 citations) and Pulmonary and Respiratory Medicine (1.2k citations). Scott S. Tykodi has collaborated with scholars based in United States, United Kingdom and Denmark. Frequent co-authors include John A. Thompson, Shailender Bhatia, Edus H. Warren, David F. McDermott, Saby George, Robert J. Motzer, Stanley R. Riddell, Hans J. Hammers, Elizabeth R. Plimack and Frede Donskov. Their work appears in journals such as Nature, Science and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.